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In the mouse, qualitative differences occur between cell types in the expres- 
sion of gene products of the H-2  major histocompatibility complex (MHC).  In 
particular,  antigenic products of the central (I)  region (Ia antigens) are ex- 
pressed by B lymphocytes and a few other cell types (1), whereas the K- and D- 
region antigens are present on practically all cells. Since strong transplantation 
antigens are  also determined by the I  region (2), the expression of its gene 
products by  different tissues  may influence the  survival  of such tissues  as 
allografts. 
In the pig, the survival of kidney allografts between siblings of known MHC 
genotype (as  defined by  mixed  lymphocyte culture  and  lymphocytotoxicity 
serotyping) shows a strong gene dose effect (3). However, liver allografts survive 
any degree of mismatching (4) and confer donor-specific protection to subsequent 
renal  grafts  (5). We  have  used  the  approach  of Davies  and  Alkins  (6)  to 
investigate the possibility that these findings may be due to antigenic differ- 
ences between liver and kidney tissues. 
Materials and Methods 
Animals.  Two  partly  inbred lines of pigs  are  available; one homozygous for the "1" MHC 
haplotype and the other for the "5" haplotype, as defined serologically. These are referred to as Sl/ 
S1 and S5/$5. 
Antiserum.  No.  4454 is one of a  bank of alloantisera used to type the Babraham pig herd. 
Microcytotoxicity testing using peripheral blood leukocyte  (PBL) targets from  145 offspring of 
backcross  matings  and  from  randomly  chosen  pigs  showed  4454  to  be  specific  for  an  MHC 
haplotype  designated  1  (7).  Cells  from  $5/$5  pigs  were  used  as  controls  in  absorptions  and 
cytotoxicity tests. 
PBL.  These were separated from citrated blood by the Ficoll-Hypaque method, and those for 
use as target cells were stored viable at -196°C. PBL for absorption were used immediately after 
preparation. 
Kidney Cells.  These were from lines established from the kidneys of S1/S1 and $5/$5 pigs. 
They synthesized large concentrations of metallothionein on exposure to cadmium salts: a  prop- 
erty specific for renal and hepatic parenchyma (8). Three lines of S1/S1 and two of $5/$5 cells were 
available. 
Liver Cells.  These were from lines obtained from the livers of 5-day-old S1/S1 or $5/$5 pigs; 
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they produced metallothionein  on exposure  to  cadmium Salts.  Nonparenchyma! cells  were elimi- 
nated by initial  cultivation  in an arginine-deficient,  ornithine-supplemented  medium (9).  Four 
lines  of  $1/$1 and one of  $5/$5  cells  were available. 
Platelets. These were isolated  from  citrated  blood  by  differential  centrifugation  (10);  a typical 
preparation  contained  I  lymphocyte per  2 x 104  platelets. 
Absorption  Methods.  Kidney  and  liver  parenchymal  cells,  washed  free  of  serum, were  scraped 
from the  surface  of  culture  bottles.  All  packed  cell  volumes  were  determined by centrifugation  at 
10  ~  g. Antiserum was diluted  50-fold  with phosphate-buffered  saline  (PBS),  pH 7.2,  and 1 ml of 
dilute  serum was added  to  40-50  pl  packed  cells  which were  resuspended and maintained  thus at 
room temperature for  30 min. Cells  were then removed by centrifugation  and the  antiserum was 
reabsorbed  by the same procedure. 
Elution  of  Antibody from Platelets. Platelets  carrying  adsorbed  antibodies  were washed thor- 
oughly with  PBS then suspended  in  glycine/hydrochloric  acid  buffer,  0.2  M, pH 3.0  for  30 min at 
room  temperature.  After  centrifugation,  the  supernate  was  dialyzed  exhaustively  against  PBS. 
Cytotoxicity Tests: PBL Targets.  Antisera were titrated against cells labeled with Na2 ~Cr O4 
(CJS 4; The Radiochemical Centre, Amersham, Great  Britain) using standard  methods (11). 
Rabbit serum detoxified by absorption with pig erythrocytes in the presence of  EDTA (12) was the 
source of complement (C). Controls for antibody toxicity, C toxicity, and spontaneous isotope 
release  were included. 
Kidney and Liver Targets. Confluent monolayers in the wells  of Nunclon-Delta microtest 
plates  (NUNC UK Ltd.,  Stafford,  Great Britain)  each received  1 /~Ci  Nas s~Cr  04 in 25 pl phos- 
phate-buffered  Waymouth's medium MB 752/1  containing  5% fetal  calf  serum. After  incubation  at 
37°C for  1.5  h followed  by five  washes, each well  received  medium (25/~I)  antiserum (25/,l)  and 
C (25 /,I).  In controls,  medium replaced  antiserum, C, or both.  Total  releasable  isotope  was 
determined  by incubation  of  monolayers with distilled  water (75/~I).  After  1.25  h incubation  at 
37°C, 25 /~I  of  supernate from each well  was counted in a Packard 3002  gamma spectrometer 
(Packard Instrument Co.,  Inc.,  Downers Grove, Ill.)  and the counts  expressed  as a percentage 
of  total  releassble  isotope.  All assays  were done in  triplicate. 
Results 
Absorptions with Platelets.  Unabsorbed 4454 antiserum (UNABS), cytotoxic 
towards >95% PBL of $1/$1 type (Fig.  1 A; f) as shown by high isotope release 
and  confirmed  by dye exclusion,  was  absorbed  serially,  fourfold,  with  $1/$1 
platelets. The absorbed serum (ABS) was still cytotoxic towards a proportion of 
$1/$1 PBL (Fig.  1 A; a-d).  Two subpopulations of leukocytes (L1 and L2), are 
therefore distinguished.  Absorbed antibodies, eluted from platelets (ELU), and 
concentrated fourfold, were as cytotoxic as UNABS (Fig. 1 A; e, compare f). ELU 
therefore recognizes antigens present on platelets and all PBL; ABS recognizes 
antigens present on L~ but absent from platelets and LI. 
Absorptions  with Liver  Cells.  Absorption  Of ELU  with  $1/$1  liver cells 
removed essentially all cytotoxicity for $1/$1 PBL  (Fig. 1 A; g). This suggests 
that liver cells  express all antigens present on platelets. Serial fourfold absorp- 
tion  of  ABS  with liver  cells  removed little  or  no cytotoxic antibody (Fig. I B; a-d, 
and e),  and similar absorption of  4454 UNABS  yielded an antiserum of  restricted 
cytotoxicity for  $I/$1 PBL, (Fig. 1 C; a-d, and e)  apparently the same as  ABS, as 
would  be expected  if platelets and  liver cells possess an identical array of 
antigens. 
Absorption with $I/$1 Kidney Cells or  PBL.  All cytotoxic antibodies in 4454 
UNABS  (Fig.  1 D; a) were removed  by serial fourfold absorption with $1/$1 
kidney cells (Fig. 1 D; b-e) or with $1/$1 PBL  (Fig. 1 D; f). Kidney therefore 
possesses not only those antigens expressed by liver cells,  platelets, and LI, but 
also those antigens restricted to L2. DAVIES  ET  AL.  BRIEF  DEFINITIVE  REPORT  989 
50 
40 
•<20 
~ 
..J 
~u 
o 
O 
6C 
a~ 
4G 
2C 
f  A 
i~11111 
C 
CC 
1:5  ~  ~  1'2 2~  ,'8  9'6 
~CC 
I  i  i  i  i  I 
D  a 
d 
e 
--ClC  f 
1/ANTISERUM  DILUTION  x 10 2 
FIG.  1.  Cytotoxicity for S1/S1 PBL targets.  (A) a-d,  antiserum 4454 absorbed four times 
with S1/SI platelets.  Titrations made after successive absorptions gave overlapping lines 
(a-d); e,  antibodies eluted from platelets (ELU); f,  4454  UNABS; and g,  ELU reabsorbed 
with S1/S1 liver cells. (B) a-d, ABS reabsorbed four times with S1/S1 liver cells; and e, ABS. 
(C) a-d, 4454 UNABS absorbed four times with S1/S1 liver cells; and e; 4454 UNABS. (D) a, 
4454 UNABS; b-e, 4454 UNABS absorbed four times with S1/S1  kidney cells; and f,  4454 
UNABS after three absorptions with S1/S1 PBL.  C'C, C toxicity. 
Specificity  Controls.  4454 UNABS  was  not cytotoxic towards $5/$5  PBL, 
even at high concentrations (Fig.  2 A; b).  The same target cells were totally 
lysed by an antiserum specific for the $5 haplotype, (Fig.  2 A; a).  When 4454 
UNABS was serially absorbed threefold with $5/$5 PBL, cytotoxicity towards 
S1/S1 PBL was unaffected, (Fig. 2 B; a, and b); similar threefold absorption with 
S1/S1  PBL removed all cytotoxicity (Fig. 2 B; c). 
Cytotoxici~y of 4454 UNABS, ABS, and ELU Towards Liver and Kidney Cell 
Monolayers.  When  S1/S1  monolayers from the  same  animal  were  used  as 
targets, 4454 UNABS and ELU were cytotoxic for both liver and kidney (Fig. 3 
A and B; a, and c) while ABS was cytotoxic for kidney but had no measurable 
effect on liver (Fig. 3 A and B; b). Identical results have been obtained with all 
available cell lines (three kidney and four liver) derived from different S1/S1 
pigs. These results confirm the assignments of antigen expression based on the 
absorption studies described. 
Unexpectedly, however, 4454 UNABS and ABS have always shown definite 
cytotoxicity towards "nonspecific" $5/$5 kidney monolayers, (Fig. 3 D; a, b, c, 
and d) which may be removed by absorption with $5/$5 kidney cells (Fig. 3 D; e, 
and f).  This also reduced cytotoxicity for S1/S1 kidney monolayers, (Fig.  3 C; 
compare c, and d: e, and f). This nonspecific killing contrasts with the lack of 
cytotoxicity of 4454 UNABS for $5/$5 PBL derived from the same animal (Fig. 2 
A; b), even at a  much higher concentration, and despite the fact that PBL are 990  DAVIES  ET  AL.  BRIEF  DEFINITIVE  REPORT 
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Fro.  2.  Specificity controls. (A) $5/S5 PBL targets: a, effect of anti-S5 serum; and b, effect 
of 4454 (UNABS). (B) S1/S1 PBL targets: a, effect of antiserum 4454 (UNABS); b, after three 
absorptions with $5/$5 PBL; and c, after three absorptions with S1/S1 PBL. 
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Cytotoxicity  for  kidney and liver  cell  monolayers: (triplicate  assays;  in  each  group, 
left  block contains antibody plus C; right  contains antibody plus medium). (A and B) SI/SI 
liver  and kidney from the same animal: a, 4454 (UNABS) at 1/15o  dilution;  b, 4454 ABS at 
I/iso  dilution;  and c, ELU  at 1/15o  equivalent concentration. (C and D) $1/$1 and $5/$5 
kidney: 4454 UNABS  diluted  (a) I/xso;  and (b) 1/46o.  ABS diluted  (c) 1/15o;  and (d) 1/45o.  ABS 
after  four absorptions with $5/$5 kidney cells:  diluted (e) x/15o;  and (f) I/4so.  n, release of 
isotope  by cells  in medium only;  c', C control  (cells  plus C plus medium). 
more sensitive targets. Preliminary evidence shows that absorption of 4454 with 
$5/$5 kidney cells does not affect its cytotoxic titer for S1/S1 PBL but absorption 
of 4454 with S1/S1 PBL, which removes all cytotoxicity for the same target cells, 
fails to affect the nonspecific killing of $5/$5 kidney monolayers.  Nonspecific 
cytotoxicity for $5/$5 liver cells has not been found. These results indicate that 
some alloantigens present on kidney cells and skin (since antiserum 4454 was 
raised by skin grafting)  are absent from PBL, platelets, and liver cells. DAVIES  ET  AL.  BRIEF  DEFINITIVE  REPORT,  991 
Discussion 
In mice, the K,/,  and D  regions of the MHC all determine transplantation 
antigens and there appears to be a cumulative effect between K- and/-region 
differences on the rate of skin graft rejection (2). In rats,  the fate of kidney 
allografts is determined quantitatively by the degree of disparity between donor 
and recipient for gene products of the MHC (13). In man, similar observations 
have been made for skin grafts between related individuals genotyped for HL-A 
antigens (14). In pigs, the fate of kidney allografts between siblings depends on 
the degree of disparity of MHC gene products, but liver allografts survive even 
when totally disparate. This may be due either to unique properties of liver, 
unrelated to its antigenicity, or to antigenic deficiencies relative to kidney. The 
latter could arise either through a relative deficiency of liver cells in antigens 
common to all tissues, or through an absence of certain antigens from liver. The 
present study supports the second possibility by showing that liver cells do lack 
antigens present on kidney cells. Some of these antigens are lymphocyte  alloan- 
tigens of the MHC and resemble Ia antigens of the mouse in showing restricted 
expression on a lymphocyte subpopulation. Other antigens, less well character- 
ized, are apparently shared by skin and kidney but absent from leukocytes and 
liver. 
It is proposed that the acceptance of liver allografts despite MHC disparity is 
due to the presentation by the graft of a limited array of alloantigens insufficient 
to provoke rejection. Primary vascularization of the graft and the release of 
soluble  antigen  may also  favor the  induction of tolerance or enhancement. 
Subsequent transplantation of a kidney from the same donor would then con- 
front the recipient with yet another limited array of alloantigens, those present 
on kidney but absent from liver. This would in turn favor unresponsiveness and 
the donor-specific prolongation of kidney allografts already reported (5). 
Summary 
Evidence is presented that there are differences  between pig liver and kidney 
parenchymal cells in the expression of major histocompatibility complex anti- 
gens.  Analogues of/-region antigens of the mouse are detectable on kidney 
cells and some peripheral blood leukocytes (PBL) but not on liver, platelets, and 
other PBL.  Such differences between liver and kidney may explain (a) the fate 
of these organs as allografts and (b) the donor-specific protection of kidney by 
liver. Other antigens peculiar to skin and kidney have been detected but require 
further characterization. 
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